HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation

Author： Nogueira-Machado Joséé Augusto   Volpe Caroline Maria de Oliveira   Veloso Clara Araujo   Chaves Miriam Martins  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.8, 2011-08, pp. : 1023-1035

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 10, 2018-03 ,pp. : 1066-1079

Bentham Science Publishers

Access to resources Recommend Favorite

IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 3, 2018-04 ,pp. : 241-250

Bentham Science Publishers

Access to resources Recommend Favorite

LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications

By Yan Meiling  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 5, 2011-10 ,pp. : 451-459

Springer Publishing Company

Access to resources Recommend Favorite

Review: Therapeutic Targeting of HMGB1 in Stroke

By  

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 785-790

Bentham Science Publishers

Access to resources Recommend Favorite

RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease

By Hudson Barry I.   Schmidt Ann Marie  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1079-1086

Springer Publishing Company

Access to resources Recommend Favorite